»

DrugPatentWatch

DrugPatentWatch Archives

You are currently viewing the 2010 archives
Click here to return to the current data set

DrugPatentWatch concentrates deep knowledge on more than 6,400 small-molecule drugs and 2,300 generic ingredients from 1,700 branded and generic pharmaceutical companies and 700 suppliers, and more than 4,400 active and expired US patents and 74,000 international patents spanning 93 countries and regional patent offices.

Tradename: ORAVIG

Summary for Tradename: ORAVIG

Patents:2
Applicants:1
NDAs:1
Suppliers: see list2
drug
patent expirations by year for
 ORAVIG

Pharmacology for Tradename: ORAVIG

Ingredient-typeAzoles
Drug ClassAzole Antifungal

Clinical Trials for: ORAVIG

Uptake of the Antifungal Miconazole and Effect on Estrogen Metabolizing Enzymes in Humans
Status: Completed Condition: Healthy

Efficacy of Slow Release Clotrimazole Varnish Treating Denture Stomatitis Comparing to Traditional Treatment of Troches
Status: Enrolling by invitation Condition: Oral Candidiasis; Denture Stomatitis

Clinical Trial of Hydroquinone Versus Miconazol in Melasma
Status: Recruiting Condition: Melasma

Effectiveness of 3% Boric Acid in 70% Alcohol Versus 1% Clotrimazole Solution in Otomycosis Patients
Status: Recruiting Condition: Otomycosis

Efficacy and Safety Study of Miconazole Lauriad to Treat Oropharyngeal Candidiasis in HIV Patients
Status: Completed Condition: HIV Infections

Comparative Efficacy of Ovule vs Tablet
Status: Completed Condition: Clotrimazole; Ovulen; Vulvovaginal Candidiasis

Study to Evaluate the Clinical Outcome in High Risk Patients Who Received Empirical Antifungal Therapy
Status: Active, not recruiting Condition: Antifungal Therapy

Antifungal Use in Oncohematological Neutropenic Patients
Status: Completed Condition: Invader Fungal Infection

Antifungal Locks to Treat Fungal-Related Central Line Infections
Status: Recruiting Condition: Central Line Fungal Infections

Comparison of Two Topical Formulations Containing Clindamycin and Clotrimazole in Patients With Vaginal Infections
Status: Completed Condition: Vaginal Infections

Courtesy of ClinicalTrials.org
See more clinical trials for this drug
Glossary
Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD Patent No. Product Substance Delist_Flag Patent Expiration Exclusivity Expiration
Bioalliance Pharma
ORAVIG
miconazole
TABLET; BUCCAL022404Apr 16, 2010RXYes<disabled><disabled>
Bioalliance Pharma
ORAVIG
miconazole
TABLET; BUCCAL022404Apr 16, 2010RXYes6,916,485Y<disabled><disabled>
Bioalliance Pharma
ORAVIG
miconazole
TABLET; BUCCAL022404Apr 16, 2010RXYes7,651,698<disabled><disabled>
The preview shows a limited data set. Complete access is available with a Subscription
first patents previous patents next patents last patents

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.

Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided information. There is no warranty that the information contained herein is error free. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Sign up for a free trial

No commitment, no credit card required
First name
Last name
Email address

Connect with Social Media:

Follow DrugPatentWatch on Twitter Connect with DrugPatentWatch on Linkedin Drug Patents on LinkedIn

Copyright © 2002-2013 thinkBiotech LLC. ISSN: 2162-2639


`abc